Study on the hypercoagulable state in patients with angina and myocardial infarction
Insights
Platelet activation, coagulation, and fibrinolysis markers are elevated in coronary heart disease (CHD), particularly in unstable angina (UA) and acute myocardial infarction (AMI) patients. These findings indicate increased thrombotic activity in advanced stages of CHD.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Biochemistry
Background:
- Coronary heart disease (CHD) involves complex hemostatic alterations.
- Platelet activation, coagulation, and fibrinolysis are key components of cardiovascular thrombosis.
Purpose of the Study:
- To investigate molecular markers of platelet activation, coagulation, and fibrinolysis in different stages of CHD.
- To differentiate hemostatic profiles between stable angina (SA), unstable angina (UA), and acute myocardial infarction (AMI).
Main Methods:
- Analysis of platelet granule membrane protein 140 (GMP-140) for platelet activation.
- Measurement of prothrombin fragment F1 + 2 and fibrinopeptide A (FPA) for coagulation activation.
- Detection of D-dimer and alpha 2-plasma inhibitor (alpha 2-PI) for fibrinolytic state assessment.
Main Results:
- Elevated GMP-140 levels in all CHD groups suggest general platelet activation.
- Significantly higher prothrombin fragment F1 + 2 and FPA levels in UA and AMI compared to SA and controls indicate enhanced coagulation.
- Increased D-dimer and alpha 2-PI in UA and AMI groups suggest activated fibrinolysis.
Conclusions:
- Platelet activation is present across CHD spectrum.
- Coagulation and fibrinolytic systems are significantly activated in unstable angina and acute myocardial infarction.
- These markers may aid in assessing CHD severity and thrombotic risk.
Abstract:
The molecular markers of platelet activation, coagulation and fibrinolysis were detected in 60 cases of coronary heart disease (CHD), including 15 cases of stable angina (SA), 21 cases of unstable angina (UA) and 24 cases of acute myocardial infarction (AMI). The results showed that the platelet granule membrane protein 140 (GMP-140) level increased obviously in CHD groups compared with normal control, suggesting that platelet activation existed in CHD. Prothrombin fragment F1 + 2 and fibrinopeptide A (FPA) were examined to observe the activation of coagulation. No difference was found between SA group and normal controls, while their levels in both UA group and AMI group were significantly higher than in normal control and SA group (both P < 0.05). D-D dimer and alpha 2-plasma inhibitor (alpha 2-PI) were detected to observe fibrinolytic state. The results showed that no difference existed between SA group and normal controls, while both D-D dimer and alpha 2-PI in UA group and AMI group were significantly elevated than those in SA group and normal controls (P < 0.05).
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Angina III: Clinical Manifestations and Assessment
Angina IV: Management
Angina V: Nursing Management


